300328EontecSZSE

Dongguan Eontec Co., Ltd.

宜安科技

300328

Shenzhen Stock Exchange

BoardChiNext of Shenzhen Stock Exchange
IndustryMetal Products
ListedJune 19, 2012
Websitewww.e-ande.com
IR Emaileon@e-ande.com
Phone(+86)0769-87387777
Sourcecninfo.com.cn
AddressYinquan Industrial Zone, Qingxi Town, Dongguan, Guangdong

Company Overview

Dongguan Eontec Co., Ltd. is a national high-tech enterprise listed on the ChiNext board of the Shenzhen Stock Exchange since 2012. The company specializes in the research, design, production, and sales of new materials, positioning itself as a leading player in the metal products manufacturing sector in China. Eontec integrates material research, precision mold development, die-casting, CNC machining, and surface treatment processes to deliver innovative and high-quality solutions to its customers. Eontec's main business lines include new energy vehicles, liquid metal products, and biodegradable medical magnesium alloys. The company has established itself as a pioneer in developing lightweight materials for new energy vehicles, leveraging advanced die-casting technology and intelligent manufacturing processes. In the liquid metal sector, Eontec has developed a significant production line for amorphous alloys, catering to various applications, including consumer electronics and medical devices. Additionally, Eontec is recognized for its biodegradable medical magnesium alloys, having achieved notable milestones in clinical trials and industry standards, further solidifying its competitive position in the biomedical materials field.

AI-generated from company disclosures and CNInfo data.

Company Profile

1、New Energy Vehicles EONTEC is one of the earliest enterprises in the world to invest in large-scale magnesium and aluminum die-casting equipment, with a long-term commitment to developing new lightweight materials for new energy vehicles. It excels in technological innovation, production capacity, and site management for NEV lightweight materials, boasting leading R&D capabilities in mold design, advanced material technology, and surface treatment and other fields. with strong lean production capacity and complete industrial chain advantages. By fully implementing the intelligent MES and building an industrial 4.0 intelligent manufacturing factory, EONTEC has achieved digital and intelligent production management, driving simultaneous improvements in both efficiency and product quality, and have great advantages in the integrated molding of large parts of new energy vehicles, with large-scale die-casting equipments (incl. 6100T, 4200T, 3500T, 2700T, and 1600T models), this can fulfill production needs of different specifications. At present, it has been applied in the electric motor, electric control, battery pack, instrument panel, door latch and other products of new energy vehicles. 2、Liquid metal EONTEC has more than 20 years of experience in new material research and development, precision molding design, mechanical preparation, die-casting molding and production, focus on liquid metal research and development and industrialization for more than 10 years, as an earlier liquid metal research and development enterprise in the industry, it has independent intellectual property rights in many aspects of amorphous alloy composition, forming technology and equipment, and has the full process capabilities of amorphous alloy material composition design, master alloy melting, precision mold design and manufacturing, precision machining, surface treatment and liquid metal vacuum forming equipment manufacturing. It has the largest scaled production line of amorphous alloy in China. After years of technology and market accumulation, EONTEC has achieved industry-leading advantages in the application and industrialization of bulk amorphous alloys, successfully developed and produced bulk amorphous products. EONTEC’s liquid metal applications mainly divided into four sectors: the first sector is consumer electronics structural parts (including hinges, wearable devices and mobile phone precision structural parts etc.); the second sector is new energy vehicle parts; the third sector is medical device structural parts; the fourth sector is music and sports equipment structural parts. 3、Medical Magnesium Alloy The biodegradable medical magnesium alloy project is one of the important directions of the company’s development, its R&D team “biodegradable medical magnesium alloy and related implanted device innovation R&D team” is the second batch of innovative scientific research teams introduced by Guangdong Province. EONTEC is an enterprise with core competence in the field of biomedical materials, is the chairman unit of the medical magnesium alloy industry technology innovation alliance, is a pioneer in the development of industry standards, clinic and industrialization in China. It has strong scientific research and industrialization capabilities in biodegradable medical magnesium alloys, strong scientific research cluster competitive advantage, and strong industry influence. In July 2019, EONTEC ‘s degradable magnesium internal fixation screw clinical trial approval was officially passed, it is the first biodegradable metal screw approved for clinical use in China, and also the first clinic trial of pure magnesium (the purity is 99.99wt.%) as an internal implant in the world. In May 2020, EONTEC RECEIVED THE CE certificate of degradable magnesium internal fixation screw issued by the international authoritative European Union certification notified body UDEM. Globally EONTEC obtained the first approval certificate of this indication product. ‌ In February 2023, the clinical trial for the degradable magnesium internal fixation screw cumulatively enrolled 184 cases across 9 domestic clinical research centers with full enrollment completion. In December 2024, EONTEC received the clinical trial summary report for the degradable magnesium internal fixation screw. Ater more than 10 years of accumulation, EONTEC has established a first-class team, high technical barriers, strong partner and other core advantages in biodegradable medical magnesium alloys.

81 announcements tracked· Last: July 30, 2026

Key Financials

Revenue¥355.1M
Net Profit-¥19.2M
ROE-1.86%
Debt Ratio62.52%
Monetary Funds¥240.0M
Receivables¥521.5M
Goodwill¥13.8M
Total Shares690.4M

Announcements

81 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.